Chartwell Investment Partners, LLC Invitae Corp Transaction History

Chartwell Investment Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$24.31 - $33.6 $735,012 - $1.02 Million	-30,235 Closed	0 $0
Q2 2021 Jul 19, 2021	BUY	$26.09 - $40.4 $7,096 - $10,988	272 Added 0.91%	30,235 $1.02 Million
Q1 2021 May 03, 2021	SELL	$33.06 - $56.93 $53,193 - $91,600	-1,609 Reduced 5.1%	29,963 $1.15 Million
Q4 2020 Feb 09, 2021	BUY	$39.09 - $57.4 $429,911 - $631,285	10,998 Added 53.46%	31,572 $1.32 Million
Q3 2020 Nov 16, 2020	BUY	$28.43 - $44.67 $584,918 - $919,040	20,574 New	20,574 $892,000

1.69M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.